Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation

Condition:   Atrial Fibrillation Interventions:   Drug: Apixaban;   Drug: Warfarin Sponsors:   Mayo Clinic;   Pfizer;   Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials